209 related articles for article (PubMed ID: 34461601)
21. LRH1-driven transcription factor circuitry for hepatocyte identity: Super-enhancer cistromic analysis.
Joo MS; Koo JH; Kim TH; Kim YS; Kim SG
EBioMedicine; 2019 Feb; 40():488-503. PubMed ID: 30638865
[TBL] [Abstract][Full Text] [Related]
22. Selective transcriptional regulation by Myc in cellular growth control and lymphomagenesis.
Sabò A; Kress TR; Pelizzola M; de Pretis S; Gorski MM; Tesi A; Morelli MJ; Bora P; Doni M; Verrecchia A; Tonelli C; Fagà G; Bianchi V; Ronchi A; Low D; Müller H; Guccione E; Campaner S; Amati B
Nature; 2014 Jul; 511(7510):488-492. PubMed ID: 25043028
[TBL] [Abstract][Full Text] [Related]
23. A hypermethylation strategy utilized by enhancer-bound CARM1 to promote estrogen receptor α-dependent transcriptional activation and breast carcinogenesis.
Peng BL; Li WJ; Ding JC; He YH; Ran T; Xie BL; Wang ZR; Shen HF; Xiao RQ; Gao WW; Ye TY; Gao X; Liu W
Theranostics; 2020; 10(8):3451-3473. PubMed ID: 32206101
[TBL] [Abstract][Full Text] [Related]
24. Role of CD200 in differential diagnosis of mature B-cell neoplasm.
Rahman K; Kumar P; Gupta R; Singh MK; Nityanand S
Int J Lab Hematol; 2017 Aug; 39(4):384-391. PubMed ID: 28422443
[TBL] [Abstract][Full Text] [Related]
25. BCL6 programs lymphoma cells for survival and differentiation through distinct biochemical mechanisms.
Parekh S; Polo JM; Shaknovich R; Juszczynski P; Lev P; Ranuncolo SM; Yin Y; Klein U; Cattoretti G; Dalla Favera R; Shipp MA; Melnick A
Blood; 2007 Sep; 110(6):2067-74. PubMed ID: 17545502
[TBL] [Abstract][Full Text] [Related]
26. Three-step transcriptional priming that drives the commitment of multipotent progenitors toward B cells.
Miyai T; Takano J; Endo TA; Kawakami E; Agata Y; Motomura Y; Kubo M; Kashima Y; Suzuki Y; Kawamoto H; Ikawa T
Genes Dev; 2018 Jan; 32(2):112-126. PubMed ID: 29440259
[TBL] [Abstract][Full Text] [Related]
27. Transcriptional circuits in B cell transformation.
Hu Y; Yoshida T; Georgopoulos K
Curr Opin Hematol; 2017 Jul; 24(4):345-352. PubMed ID: 28463873
[TBL] [Abstract][Full Text] [Related]
28. [Analysis of genomic copy number alterations of malignant lymphomas and its application for diagnosis].
Tagawa H
Gan To Kagaku Ryoho; 2007 Jul; 34(7):975-82. PubMed ID: 17637530
[TBL] [Abstract][Full Text] [Related]
29. The BCL6-associated transcriptional co-repressor, MTA3, is selectively expressed by germinal centre B cells and lymphomas of putative germinal centre derivation.
Jaye DL; Iqbal J; Fujita N; Geigerman CM; Li S; Karanam S; Fu K; Weisenburger DD; Chan WC; Moreno CS; Wade PA
J Pathol; 2007 Sep; 213(1):106-15. PubMed ID: 17573669
[TBL] [Abstract][Full Text] [Related]
30. A B Cell Regulome Links Notch to Downstream Oncogenic Pathways in Small B Cell Lymphomas.
Ryan RJH; Petrovic J; Rausch DM; Zhou Y; Lareau CA; Kluk MJ; Christie AL; Lee WY; Tarjan DR; Guo B; Donohue LKH; Gillespie SM; Nardi V; Hochberg EP; Blacklow SC; Weinstock DM; Faryabi RB; Bernstein BE; Aster JC; Pear WS
Cell Rep; 2017 Oct; 21(3):784-797. PubMed ID: 29045844
[TBL] [Abstract][Full Text] [Related]
31. Role of the tumor microenvironment in mature B-cell lymphoid malignancies.
Fowler NH; Cheah CY; Gascoyne RD; Gribben J; Neelapu SS; Ghia P; Bollard C; Ansell S; Curran M; Wilson WH; O'Brien S; Grant C; Little R; Zenz T; Nastoupil LJ; Dunleavy K
Haematologica; 2016 May; 101(5):531-40. PubMed ID: 27132279
[TBL] [Abstract][Full Text] [Related]
32. What are super-enhancers?
Pott S; Lieb JD
Nat Genet; 2015 Jan; 47(1):8-12. PubMed ID: 25547603
[TBL] [Abstract][Full Text] [Related]
33. Methylome-based cell-of-origin modeling (Methyl-COOM) identifies aberrant expression of immune regulatory molecules in CLL.
Wierzbinska JA; Toth R; Ishaque N; Rippe K; Mallm JP; Klett LC; Mertens D; Zenz T; Hielscher T; Seifert M; Küppers R; Assenov Y; Lutsik P; Stilgenbauer S; Roessner PM; Seiffert M; Byrd J; Oakes CC; Plass C; Lipka DB
Genome Med; 2020 Mar; 12(1):29. PubMed ID: 32188505
[TBL] [Abstract][Full Text] [Related]
34. Transcription factor B-cell-specific activator protein (BSAP) is differentially expressed in B cells and in subsets of B-cell lymphomas.
Krenacs L; Himmelmann AW; Quintanilla-Martinez L; Fest T; Riva A; Wellmann A; Bagdi E; Kehrl JH; Jaffe ES; Raffeld M
Blood; 1998 Aug; 92(4):1308-16. PubMed ID: 9694719
[TBL] [Abstract][Full Text] [Related]
35. Co-occupancy by multiple cardiac transcription factors identifies transcriptional enhancers active in heart.
He A; Kong SW; Ma Q; Pu WT
Proc Natl Acad Sci U S A; 2011 Apr; 108(14):5632-7. PubMed ID: 21415370
[TBL] [Abstract][Full Text] [Related]
36. cis-Regulatory Circuits Regulating NEK6 Kinase Overexpression in Transformed B Cells Are Super-Enhancer Independent.
Huang Y; Koues OI; Zhao JY; Liu R; Pyfrom SC; Payton JE; Oltz EM
Cell Rep; 2017 Mar; 18(12):2918-2931. PubMed ID: 28329684
[TBL] [Abstract][Full Text] [Related]
37. Expression of A-myb, but not c-myb and B-myb, is restricted to Burkitt's lymphoma, sIg+ B-acute lymphoblastic leukemia, and a subset of chronic lymphocytic leukemias.
Golay J; Luppi M; Songia S; Palvarini C; Lombardi L; Aiello A; Delia D; Lam K; Crawford DH; Biondi A; Barbui T; Rambaldi A; Introna M
Blood; 1996 Mar; 87(5):1900-11. PubMed ID: 8634438
[TBL] [Abstract][Full Text] [Related]
38. CXCR4 expression functionally discriminates centroblasts versus centrocytes within human germinal center B cells.
Caron G; Le Gallou S; Lamy T; Tarte K; Fest T
J Immunol; 2009 Jun; 182(12):7595-602. PubMed ID: 19494283
[TBL] [Abstract][Full Text] [Related]
39. Histone H1 loss drives lymphoma by disrupting 3D chromatin architecture.
Yusufova N; Kloetgen A; Teater M; Osunsade A; Camarillo JM; Chin CR; Doane AS; Venters BJ; Portillo-Ledesma S; Conway J; Phillip JM; Elemento O; Scott DW; Béguelin W; Licht JD; Kelleher NL; Staudt LM; Skoultchi AI; Keogh MC; Apostolou E; Mason CE; Imielinski M; Schlick T; David Y; Tsirigos A; Allis CD; Soshnev AA; Cesarman E; Melnick AM
Nature; 2021 Jan; 589(7841):299-305. PubMed ID: 33299181
[TBL] [Abstract][Full Text] [Related]
40. Systematic analysis of enhancer regulatory circuit perturbation driven by copy number variations in malignant glioma.
Xiao J; Jin X; Zhang C; Zou H; Chang Z; Han N; Li X; Zhang Y; Li Y
Theranostics; 2021; 11(7):3060-3073. PubMed ID: 33537074
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
